We are live on ! Find out more
NVO

Novo Nordisk
NVO

Fund managers haven’t disclosed any holdings of NVO yet.

NVO Hedge Fund Activity: Q1 2026 in Review

1,272 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q1 2026, worth a combined $12.4B — down 23% from $16.1B a quarter earlier.

Sellers outnumbered buyers: 271 funds closed out of NVO and 148 opened new positions — a net loss of 123 holders — while 473 trimmed existing stakes and 446 added.

The largest buyer was Dodge & Cox, opening a new position worth an estimated $916M. The largest seller was Fidelity Investments, cutting an estimated $411M.

  • 1,272 institutional investors held Novo Nordisk (NVO) as of Q1 2026, down from 1,413 in Q4 2025.
  • Funds reported $12.4B of Novo Nordisk stock for Q1 2026, down 23% quarter-over-quarter.
  • 148 funds opened new Novo Nordisk positions in Q1 2026 and 271 closed out, a net change of -123 holders.
  • The largest Novo Nordisk buyer in Q1 2026 was Dodge & Cox, an estimated $916M added.
  • The largest Novo Nordisk seller in Q1 2026 was Fidelity Investments, an estimated $411M sold.

Based on aggregated 13F filings for Q1 2026.